The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting...http://www.google.es/patents/US20060228349?utm_source=gb-gplus-sharePatente US20060228349 - Anti-ADDL antibodies and uses thereof
Número de solicitud: 11/256,332 Número de publicación: US 2006/0228349 A1 Fecha de presentación: 21 Oct 2005 Patente emitida: US7780963 ( Fecha de emisión 24 Ago 2010)
